Harold M. HOFFMAN, Individually and on behalf of those similarly situated v. NUTRACEUTICAL CORPORATION
No. 13-3482
United States Court of Appeals, Third Circuit
April 10, 2014
563 F. App‘x 183
Submitted Under Third Circuit LAR 34.1(a) March 27, 2014.
IV.
We have considered all of the appellants’ other arguments and conclude that they are without merit. For the foregoing reasons, we will affirm their convictions.
Harold M. Hoffman, Englewood, NJ, pro se.
Daniel J. Gerber, Esq., Rumberger, Kirk & Caldwell, Orlando, FL, Michael R. O‘Donnell, Esq., Riker, Danzig, Scherer, Hyland & Perretti, Morristown, NJ, for Defendant-Appellee.
Before: FUENTES, SHWARTZ, Circuit Judges, and ROSENTHAL, District Judge.1
OPINION OF THE COURT
FUENTES, Circuit Judge.
Harold M. Hoffman appeals the District Court‘s order denying his motion to remand his putative class action to state court. Because the District Court had subject matter jurisdiction over this action, we affirm.
I.
Hoffman is a citizen of New Jersey. He is an attorney who has made a habit of filing class actions in which he serves as both the sole class representative and sole class counsel. See, e.g., Hoffman v. DSE Healthcare Solutions, LLC, No. 13 Civ. 7582, 2014 WL 1155472, at *2 (D.N.J. Mar. 21, 2014); Hoffman v. Lumina Health Prods., Inc., No. 13 Civ. 4936, 2013 WL 5773292, at *2 (D.N.J., Dec. 17, 2013); Hoffman v. Natural Factors Nutritional Prods., No. 12 Civ. 7244, 2013 WL 5467106, at *1 (D.N.J. Sept. 30, 2013). Nutraceutical Corporation is a Delaware corporation with its principle place of business in the State of Utah.
Hoffman filed this suit against Nutraceutical in the Superior Court of New Jersey, Bergen County. The action concerns a Nutraceutical supplement, KALO Glucosamine Chondroitin MSM, which purports to stem the progression of osteoarthritis and reduce related joint pain. Hoffman, who bought a $20 bottle of the supplement, alleges that Nutraceutical falsely represented that the supplement was “of the highest quality,” when in fact the “product was polluted and contaminated by significant concentrations of lead.” App. 33. Hoffman brought the suit “individually and [o]n behalf of others similarly situated pursuant to New Jersey Court Rule 4:32,” with a “proposed Class consist[ing] of all nationwide purchasers of KAL Glucosamine Chondroitin MSM for the six year period preceding the filing of this suit.” App. 39.
The Complaint asserts violations of the New Jersey Consumer Fraud Act,
Hoffman is the sole class representative of the putative class, although the Complaint acknowledges that Hoffman “may identify and propose additional class representative with the filing of Plaintiff‘s motion for class certification.” App. 41. Hoffman is also counsel for the proposed class.
Shortly after Hoffman filed this action in state court, Nutraceutical removed the case to the United States District Court for the District of New Jersey, under the Class Action Fairness Act of 2005 (“CAFA“). Hoffman moved to remand.
II.
Hoffman‘s sole argument on appeal is that the District Court erred by failing to remand the case to state court for lack of subject matter jurisdiction. Remand to state court is required “[i]f at any time before final judgment it appears that the district court lacks subject matter jurisdiction.”
With certain exceptions not relevant here, CAFA grants federal courts original jurisdiction over actions in which: (1) the matter constitutes a “class action“; (2) “the matter in controversy exceeds the sum or value of $5,000,000, exclusive of interest and costs“; (3) CAFA‘s minimal diversity requirements are met; and (4) there are at least 100 members of the putative class.
Where, as here, the plaintiff does not specifically aver that the amount in controversy falls below CAFA‘s $5 million threshold, the case must be remanded to state court if it is “a legal certainty” that CAFA‘s amount in controversy requirement cannot be met. Frederico v. Home Depot, 507 F.3d 188, 197 (3d Cir.2007); see also Hayes v. Wal-Mart Stores, Inc., 725 F.3d 349, 353 n. 2 (3d Cir.2013) (declining to dismiss a class action for lack of subject matter jurisdiction where “the record on appeal is insufficient for us to determine that plaintiff cannot meet the $5,000,000 amount-in-controversy requirement to a legal certainty“). Hoffman claims to have “carried his burden of evidencing to a legal certainty that he cannot recover the $5 million CAFA minimum.” Appellant‘s Br. at 7. His arguments is as follows: because Hoffman is both the sole class representative and the sole attorney for the class, the purported class cannot possibly be certified under established Third Circuit law. See Kramer v. Scientific Control Corp., 534 F.2d 1085, 1090 (3d Cir.1976). Thus, he reasons, the amount in controversy of the action—as least while the case remains in federal court—is tantamount to the value of Hoffman‘s individual claim, roughly $200, rather than the aggregate value of the class members’ claims, which would easily exceed $5 million. In other words, because it is a “legal certainty” that the class will not be certified, it follows that it is a “legal certainty” that the amount in controversy requirement cannot be met.
Hoffman‘s argument is contravened by the plain language of CAFA, which man-
It is beyond dispute that this action was filed under a state statute “similar” in nature to Rule 23. See Riley v. New Rapids Carpet Ctr., 61 N.J. 218, 294 A.2d 7, 11 (1972) (explaining that New Jersey Rule 4:32 is a “replica” of Rule 23). Moreover, Hoffman cannot demonstrate to a legal certainty that the claims of the purported class—i.e., the “nationwide purchasers” of the supplement “for the six year period preceding the filing of this suit,” App. 39—are worth $5 million or less. Accordingly, this action satisfies CAFA‘s amount in controversy requirement, and the District Court properly concluded that it had subject matter jurisdiction over Hoffman‘s suit.
III.
For the foregoing reasons, we affirm the District Court‘s denial of Hoffman‘s motion to remand. All costs will be taxed against the Appellant.
